Evidence map›Paper›PMID 42240394›Full record

ArticleThe Biochemical journal2026

An S752D activation loop mutation dynamically primes Muscle-Specific Kinase for activation.

Jakob J Prömer, James W Murphy, Mark A Lemmon, Yuko Tsutsui, Ruth Herbst

Abstract read
In one paragraph

Article in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jakob J PrömerInstitute for Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-3357-0128
James W MurphyYale Cancer Biology Institute, West Haven, CT 06516, U.S.A.ORCID 0000-0002-3046-6034
Mark A LemmonYale Cancer Biology Institute, West Haven, CT 06516, U.S.A.ORCID 0000-0002-3379-5319
Yuko Tsutsui *Yale Cancer Biology Institute, West Haven, CT 06516, U.S.A.ORCID 0000-0002-3286-3295
Ruth HerbstInstitute for Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-7764-5363

Funding

Understanding Signaling by Non-Canonical Receptor Tyrosine KinasesR35GM122485 · NIGMS · YALE UNIVERSITY · PI Mark A Lemmon · 2017 to 2026
$7.9M
Austrian Science Fund (FWF) P31199-B27HHS | National Institutes of Health (NIH) R35-GM122485Marshallplan-Jubiläumsstiftung (AMPF) N/ANIGMS NIH HHS R35 GM122485OeAD-GmbH (OEAD) N/A
6 · The paper itself

Abstract

Muscle-Specific Kinase (MuSK) is a receptor tyrosine kinase essential for neuromuscular junction (NMJ) formation and maintenance, yet its regulation remains poorly understood. Crystallographic studies of wild-type MuSK revealed an autoinhibited conformation with tyrosines in the activation loop (A-loop) anchored within the catalytic cleft to stabilize the closed, inactive conformation. We showed previously that additional phosphorylation of an A-loop serine may 'prime' MuSK for activation to sensitize it to ligand(s) in certain settings. Here, we employed crystallography, biochemical assays, and hydrogen-deuterium exchange and mass spectrometry (HDX-MS) to test this hypothesis. We found that introducing a phosphomimetic S752D mutation disrupts autoinhibitory A-loop interactions to increase ATP-binding affinity and catalytic turnover. Using HDX-MS, we further observed that the S752D mutation increases A-loop structural flexibility to relieve autoinhibition. The S752D mutation also stabilizes the juxtamembrane NPXY motif region, a docking site for the adaptor Dok7, possibly priming MuSK for downstream signaling. Together, these findings reveal dynamic transitions that underlie relief of MuSK autoinhibition and provide a mechanistic framework for understanding MuSK activation at the NMJ.

Indexed as

MutationReceptor Protein-Tyrosine KinasesReceptors, CholinergicAnimalsCrystallography, X-RayEnzyme ActivationHumansHydrogen Deuterium Exchange-Mass SpectrometryModels, MolecularMuscle ProteinsPhosphorylationProtein ConformationDOK7 protein, humanMuscle ProteinsMUSK protein, humanReceptor Protein-Tyrosine KinasesReceptors, CholinergicA-loop autoinhibitionhydrogen-deuterium exchange mass spectrometrymuscle-specific kinaseneuromuscular junctionreceptor tyrosine kinases

Identifiers

PMID42240394
PMCPMC13305817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.